Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACE527 Efficacy Against ETEC Challenge
NCT01060748Phase 2Completed
- Start
- Mar 2010
- Primary completion
- Oct 2010
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ACE527 in enterotoxigenic Escherichia coli infection. Started Mar 2010; status: completed.
02
Drugs
ACE527
03
Conditions
enterotoxigenic Escherichia coli infection
Beyond the preview
Go deeper on NCT01060748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01060748.